Company / EPS (Diluted)
PLUS THERAPEUTICS, INC. EPS (Diluted) History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.34
FY2025
5-year range
-$8.23 / -$1.28
FY2021-FY2025
Trend
+44.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 10 years, ranging from $-8.23 in FY2018 to $-0.39 in FY2015.
Based on SEC 10-K filings.
-2.34 in FY2025.
Improved from $-8.23 to $-2.34 over the past 7 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 44.8% year-over-year.
- Peak eps (diluted) was recorded in FY2015.
- Lowest eps (diluted) in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.34 | +44.8% |
| FY2024 | -$4.24 | +48.5% |
| FY2018 | -$8.23 | -543.0% |
| FY2017 | -$1.28 | +38.2% |
| FY2016 | -$2.07 | -430.8% |
| FY2015 | -$0.39 | +29.1% |
| FY2014 | -$0.55 | +9.8% |
| FY2013 | -$0.61 | -1.7% |
| FY2012 | -$0.60 | +7.7% |
| FY2011 | -$0.65 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026